Keyphrases
Allergic Diseases
83%
Interleukin-33 (IL-33)
60%
Dectin-1
52%
Drug Combination
52%
Persisters
52%
Epithelial Cells
43%
Clinafloxacin
37%
Allergen
36%
Lung Cancer
31%
Urban Particulate Matter
31%
ILC2
31%
Dysregulated
31%
Interleukin-13 (IL-13)
31%
Gentamicin
29%
Biofilm Infection
29%
Cefepime
26%
Phagolysosome
26%
Neurogenic Inflammation
26%
Mast Cells
26%
Pseudomonas Aeruginosa Infection
26%
Specific Receptor
26%
Associated Genes
26%
Nrf2 Activation
26%
CD73
26%
Staphylococcus Aureus Biofilm
26%
Cystic Fibrosis
26%
MRGPRX2
26%
Invertebrates
26%
15-lipoxygenase (15-LOX)
26%
Senescence
26%
Preclinical Animal Models
26%
Allergic Airway Inflammation
26%
Cell Regulation
26%
Epigenetic Regulation
26%
Neurogenic Pain
26%
Poor Clinical Outcomes
26%
Fibrosis Models
26%
Air Pollution
26%
Th2 Cytokines
26%
Lipoxygenase Pathway
26%
Airway Hyperresponsiveness
26%
Hypoxia
26%
Macrophages
26%
Lung
24%
Asthma
23%
STK11
21%
Persistent Infection
21%
Epithelium
20%
Mouse Model
20%
Type 2 Response
20%
Immunology and Microbiology
Allergen
100%
Asthma
53%
Dectin 1
52%
Particulate Matter
52%
Cytokine
51%
Interleukin-33
47%
Immunocompetent Cell
40%
Interleukin 13
39%
Mouse Model
39%
Immune Response
36%
Secretion (Process)
36%
Interleukin 33
33%
Innate Lymphoid Cell
31%
Surface Property
30%
Respiratory Tract Allergy
29%
STAT3
26%
Phagolysosome
26%
Mast Cell
26%
Serum Amyloid A
26%
Programmed Death-Ligand 1
26%
Neurogenic Inflammation
26%
Pattern Recognition Receptor
26%
Perforin
26%
Allergic Airway Inflammation
26%
Pseudomonas aeruginosa
26%
Interleukin 4
26%
Cytotoxic T Cell
26%
Diptera
26%
Epigenetics
26%
Squamous Cell
26%
Macrophage
26%
Neutrophil Granulocyte
26%
Experimental Mouse
26%
Prevalence
21%
Hypersensitive Response
21%
Fas Ligand
21%
Bone Marrow-Derived Macrophage
17%
Inflammatory Disorder
17%
Target Cell
17%
Phagocytosis
17%
Neutrophil
17%
Mediator
17%
CLEC7A
15%
Biofilm
15%
Mouse
13%
Acute Phase Protein
13%
Arm
13%
Bacterial Immunity
13%
Monospecific Antibody
13%
Granulocyte Macrophage Colony-Stimulating Factor
13%
Pharmacology, Toxicology and Pharmaceutical Science
Disease
88%
Combination Drug
52%
Infection
52%
Lung Cancer
39%
Respiratory Tract Allergy
39%
Mouse Model
38%
Clinafloxacin
34%
Cytokine
30%
Gentamicin
28%
Neoplasm
26%
Pseudomonas Infection
26%
Dectin 1
26%
Experimental Mouse
26%
Cystic Fibrosis
26%
Bacterial Infection
26%
Neuropeptide
26%
Arachidonate 15 Lipoxygenase
26%
Interleukin 13
26%
Respiratory Tract Disease
26%
Interleukin 4
26%
Cefuroxime
26%
Diptera
26%
Neuropeptide FF
26%
G Protein Coupled Receptor
26%
Carbon Black
26%
Staphylococcus Aureus
26%
Lung Adenocarcinoma
19%
Anti-Inflammatory Drug
18%
Inflammation
18%
Asthma
16%
Squamous Cell Lung Carcinoma
13%
Galactosidase
13%
Pseudomonas aeruginosa
13%
Health Hazard
13%
Degenerative Disease
13%
Emphysema
13%
Life Expectancy
13%
Respiratory Tract Inflammation
13%
Interferon
13%
Allergen
13%
Immunopathology
13%
Environmental Exposure
13%
Inflammasome
13%
Long Term Exposure
13%
Scavenger Receptor
13%
Persistent Infection
12%
Receptor
10%
Inflammatory Disease
10%
Lung Infection
9%
Rifampicin
9%